Rolf Bjerkvig

Q: What Schools Are Affiliated With Rolf Bjerkvig

Rolf Bjerkvig is affiliated with the following schools: University of Amsterdam, University of Bergen

Rolf Bjerkvig's AcademicInfluence.com Rankings

Rolf Bjerkvig

Biology

#12463

World Rank

#15940

Historical Rank

Biotechnology

#220

World Rank

#222

Historical Rank

Cell Biology

#658

World Rank

#672

Historical Rank

Molecular Biology

#2021

World Rank

#2053

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Rolf Bjerkvig Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Rolf Bjerkvig's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Whole genomes redefine the mutational landscape of pancreatic cancer (2015) (1983)
DNA methylation-based classification of central nervous system tumours (2018) (1461)
Cost of migration: invasion of malignant gliomas and implications for treatment. (2003) (1136)
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells (2008) (588)
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma (2011) (586)
Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. (2009) (572)
The origin of the cancer stem cell: current controversies and new insights (2005) (456)
Glutamine Synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma (2015) (387)
Opinion: the origin of the cancer stem cell: current controversies and new insights. (2005) (325)
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment (2019) (306)
Local endostatin treatment of gliomas administered by microencapsulated producer cells (2001) (303)
Critical appraisal of the side population assay in stem cell and cancer stem cell research. (2011) (298)
Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. (2010) (280)
Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. (1990) (253)
In vivo models of primary brain tumors: pitfalls and perspectives (2012) (226)
Angiogenesis-independent tumor growth mediated by stem-like cancer cells (2006) (220)
Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen‐presenting cells (1994) (210)
Multicellular tumor spheroids from human gliomas maintained in organ culture. (1990) (199)
Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. (2006) (183)
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma (2018) (180)
Expression of extracellular matrix components in a highly infiltrative in vivo glioma model (2002) (174)
Effects of EGF, BFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain‐tumour biopsies In Vitro (1993) (165)
HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects. (2003) (161)
The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling (2008) (148)
Human α-Lactalbumin Made Lethal to Tumor Cells (HAMLET) Kills Human Glioblastoma Cells in Brain Xenografts by an Apoptosis-Like Mechanism and Prolongs Survival (2004) (147)
Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. (1986) (133)
Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma (2011) (133)
DNA repair and cancer stem-like cells--potential partners in glioma drug resistance? (2008) (130)
Cancer initiation and progression: involvement of stem cells and the microenvironment. (2007) (129)
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis (2013) (119)
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas (2014) (116)
Ciliary Neurotrophic Factor Cell-Based Delivery Prevents Synaptic Impairment and Improves Memory in Mouse Models of Alzheimer's Disease (2010) (110)
Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma (2011) (109)
Deciphering the complex role of thrombospondin-1 in glioblastoma development (2019) (107)
Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro (1997) (107)
U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells (2014) (107)
Molecular mechanisms of temozolomide resistance in glioblastoma multiforme (2012) (107)
Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. (1991) (106)
NG2 proteoglycan promotes angiogenesis‐dependent tumor growth in the central nervous system by sequestering angiostatin (2002) (105)
Interstitial fluid: the overlooked component of the tumor microenvironment? (2010) (103)
Mesenchymal stem cell signaling in cancer progression. (2013) (103)
Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. (1993) (103)
Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. (1997) (98)
Stimulation of extracellular matrix components in the normal brain by invading glioma cells (1998) (96)
Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma (2015) (94)
A reproducible brain tumour model established from human glioblastoma biopsies (2009) (93)
Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways (2017) (92)
Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes (2013) (90)
Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells. (2001) (90)
Cell encapsulation technology as a therapeutic strategy for CNS malignancies. (2001) (89)
Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF‐α, bFGF, IL‐2] on glioma spheroid growth, migration and invasion (1994) (89)
Glioma cell populations grouped by different cell type markers drive brain tumor growth. (2010) (86)
Stimulation of glioma‐cell migration by laminin and inhibition by anti‐α3 and anti‐β1 integrin antibodies (1996) (84)
Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling (2019) (83)
The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours (2002) (83)
The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells. (2013) (82)
Characteristics of human and rat glioma cells grown in a defined medium. (1988) (80)
Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells (2013) (80)
Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis (2012) (79)
Spheroid Culture in Cancer Research (1991) (78)
Transfection of glioma cells with the neural‐cell adhesion molecule NCAM: Effect on glioma‐cell invasion and growth in vivo (1994) (78)
Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy (2018) (77)
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. (2016) (76)
Inhibition of medulloblastoma cell invasion by Slit (2006) (74)
Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors (2007) (72)
Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA (2006) (72)
In vitro and in vivo models for the study of brain tumour invasion. (1997) (71)
iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype* (2009) (70)
Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats (2007) (69)
Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors (1997) (67)
Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms (2009) (67)
Migratory patterns of lac‐z transfected human glioma cells in the rat brain (1995) (66)
In vivo animal models for studying brain metastasis: value and limitations (2013) (66)
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma (2016) (65)
The origin of the cancer stem cell: current controversies and new insights (2005) (63)
Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro (1999) (63)
A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions (2008) (62)
Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion (2018) (62)
Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells (2015) (62)
Leptomeningeal tissue: a barrier against brain tumor cell invasion. (1994) (61)
PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication. (2004) (61)
Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres (2007) (59)
Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma. (2002) (59)
Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression (2003) (57)
Bromelain reversibly inhibits invasive properties of glioma cells. (2001) (57)
Remission of Invasive, Cancer Stem-Like Glioblastoma Xenografts Using Lentiviral Vector-Mediated Suicide Gene Therapy (2009) (56)
Cells encapsulated in alginate: a potential system for delivery of recombinant proteins to malignant brain tumours (1999) (55)
Immunohistochemical Expression of Stem Cell, Endothelial Cell, and Chemosensitivity Markers in Primary Glioma Spheroids Cultured in Serum‐Containing and Serum‐Free Medium (2010) (54)
Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors. (2002) (54)
Tumor cell invasion and angiogenesis in the central nervous system. (1997) (53)
Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: Effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions (2000) (52)
Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers? (2014) (51)
The angiogenic switch leads to a metabolic shift in human glioblastoma (2016) (50)
Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model. (2013) (49)
αB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells. (2010) (49)
Lymphangiogenesis in colorectal cancer—Prognostic and therapeutic aspects (2007) (48)
Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide (2018) (48)
Immunocytochemical characterization of extracellular matrix proteins expressed by cultured glioma cells. (1989) (47)
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology (2020) (47)
Imaging of Experimental Rat Gliomas Using a Clinical MR Scanner (2003) (47)
Evidence for a secreted chemorepellent that directs glioma cell invasion. (2004) (46)
Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies. (2014) (45)
Transmission and scanning electron microscopy of N2 microbubble-activated human platelets in vitro. (1987) (45)
Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma. (2019) (45)
Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas. (1997) (45)
Peptide-guided nanoparticles for glioblastoma targeting. (2019) (44)
Alginate-Encapsulated Producer Cells: A Potential New Approach for the Treatment of Malignant Brain Tumors (2000) (44)
The regulation of cysteine cathepsins and cystatins in human gliomas (2012) (44)
Intercellular transfer of transferrin receptor by a contact‐, Rab8‐dependent mechanism involving tunneling nanotubes (2015) (44)
The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors (2017) (43)
A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1 (2013) (42)
NG2 expression regulates vascular morphology and function in human brain tumours (2006) (42)
Analysis of the Growth Dynamics of Angiogenesis-Dependent and -Independent Experimental Glioblastomas by Multimodal Small-Animal PET and MRI (2012) (42)
Stimulation of glioma-cell migration by laminin and inhibition by anti-alpha3 and anti-beta1 integrin antibodies. (1996) (42)
Activated Platelets Provide a Functional Microenvironment for the Antiangiogenic Fragment of Histidine-Rich Glycoprotein (2009) (41)
Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy (2017) (41)
Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination (2017) (40)
Characterization of NCAM expression and function in BT4C and BT4Cn glioma cells (1991) (40)
Mechanisms of tumor cell invasion and angiogenesis in the central nervous system. (2003) (40)
Phagocytic capacity of normal and malignant rat glial cells in culture. (1987) (40)
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. (2016) (39)
Combretastatin A-4 and hyperthermia;a potent combination for the treatment of solid tumors. (2001) (39)
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis (2016) (39)
Interaction between human brain tumour biopsies and fetal rat brain tissue in vitro (1990) (39)
Laminin expression by glial fibrillary acidic protein positive cells in human gliomas (1999) (39)
Cell therapy using encapsulated cells producing endostatin. (2003) (38)
Cellular Host Responses to Gliomas (2012) (37)
Cell and tissue culture of the central nervous system: Recent developments and current applications (1985) (37)
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery. (2019) (37)
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells (2017) (36)
A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients (2011) (34)
Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. (2009) (34)
Whipple's disease. Demonstration of a persisting monocyte and macrophage dysfunction. (1988) (34)
Differential Activity of NADPH-Producing Dehydrogenases Renders Rodents Unsuitable Models to Study IDH1R132 Mutation Effects in Human Glioblastoma (2011) (34)
Invasive glioma cells in tissue culture. (1990) (33)
Cell therapies for glioblastoma (2006) (33)
Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein (2010) (33)
Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins (2009) (33)
The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling. (2012) (33)
Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma (2019) (32)
Effect of alkyl-lysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro. (1991) (32)
Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. (2006) (31)
Invasiveness of primary brain tumors (2004) (31)
DNA content and chromosomal composition of malignant human gliomas. (1985) (31)
A metalloproteinase, capable of destroying cultured brain tissue isolated from rat glioma cells. (1991) (31)
Tumor-penetrating peptide for systemic targeting of Tenascin-C (2020) (30)
Immunolocalization of extracellular matrix proteins during brain tumor invasion in BD IX rats. (1989) (30)
Role of high molecular weight extracellular matrix proteins in glioma cell migration (1997) (30)
Glioma cell invasion visualized by scanning confocal laser microscopy in an in vitro co-culture system. (1995) (29)
Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell‐like phenotype (2009) (28)
Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF (2013) (28)
Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-κB Signaling (2019) (27)
Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts. (2005) (27)
Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma. (2003) (27)
Cancer stem cells and angiogenesis. (2009) (27)
Matrine induces senescence of human glioblastoma cells through suppression of the IGF1/PI3K/AKT/p27 signaling pathway (2018) (26)
Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture (2004) (26)
Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)* (2015) (26)
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis (2019) (26)
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors (2019) (26)
Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype. (2009) (26)
Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. (1991) (25)
Distribution patterns of the anti-angiogenic protein ADAMTS-1 during rat development. (2005) (25)
Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects (2020) (24)
Tumor vasculature is targeted by the combination of combretastatin A-4 and hyperthermia. (2001) (24)
Prospects for delivery of recombinant angiostatin by cell-encapsulation therapy. (2003) (24)
Dynamic determination of human glioma invasion in vitro. (1998) (24)
Proliferation, migration and invasion of human glioma cells exposed to antifolate drugs (1993) (24)
In Vivo Bioluminescence Imaging Validation of a Human Biopsy–Derived Orthotopic Mouse Model of Glioblastoma Multiforme (2013) (23)
Tumor vasculature: the Achilles' heel of cancer? (2013) (23)
In Vitro Treatment of Melanoma Brain Metastasis by Simultaneously Targeting the MAPK and PI3K Signaling Pathways (2014) (23)
Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine. (1983) (23)
Therapeutic Effect of Cabazitaxel and Blood-Brain Barrier opening in a Patient-Derived Glioblastoma Model (2019) (23)
Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation (2006) (23)
Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics (2008) (23)
Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin (2019) (22)
Interaction between rat glioma cells and normal rat brain tissue in organ culture. (1985) (22)
Identification of a novel lytic peptide for the treatment of solid tumours (2014) (22)
Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment? (2014) (21)
Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment (2010) (21)
The glioma‐associated gangliosides 3′‐isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains (2001) (21)
Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma. (2017) (21)
Laminin: a potential inhibitor of rat glioma cell invasion in vitro. (1994) (20)
Cathepsin L silencing enhances arsenic trioxide mediated in vitro cytotoxicity and apoptosis in glioblastoma U87MG spheroids. (2013) (20)
Vinblastine and hyperthermia target the neovasculature in BT(4)AN rat gliomas: therapeutic implications of the vascular phenotype. (2001) (20)
Cryopreservation of Alginate-Encapsulated Recombinant Cells for Antiangiogenic Therapy (2004) (20)
The brain slice chamber, a novel variation of the Boyden Chamber Assay, allows time-dependent quantification of glioma invasion into mammalian brain in vitro (2005) (20)
Effects of high and low single dose irradiation on glioma spheroid invasion into normal rat brain tissue in vitro. (1992) (20)
Nonadhesive stationary organ culture of human bronchial mucosa. (1996) (19)
Interactions between fetal rat brain cells and mature brain tissue in vivo and in vitro (1993) (19)
Adeno‐associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma (2006) (19)
Loss of adipocyte specification and necrosis augment tumor-associated inflammation (2013) (19)
Localised delivery of therapeutic agents to CNS malignancies: old and new approaches. (2002) (19)
Oncolytic Herpes Simplex Virus Type-1 Therapy in a Highly Infiltrative Animal Model of Human Glioblastoma (2008) (18)
TGF-β promotes microtube formation in glioblastoma through thrombospondin 1 (2021) (17)
AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion (2020) (17)
Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma (2017) (16)
A cerebral glioma model for experimental therapy andin vivo invasion studies in syngeneic BD IX rats (1990) (16)
Multicellular tumor spheroids in serum-free culture. (1989) (16)
Inference of Low and High-Grade Glioma Gene Regulatory Networks Delineates the Role of Rnd3 in Establishing Multiple Hallmarks of Cancer (2015) (16)
Novel CIC Point Mutations and an Exon-Spanning, Homozygous Deletion Identified in Oligodendroglial Tumors by a Comprehensive Genomic Approach Including Transcriptome Sequencing (2013) (16)
Isolation and characterization of a metalloproteinase secreted by rat glioma cells in serum-free culture. (1990) (15)
Spontaneous Transformation of Stem Cells In Vitro and the Issue of Cross-Contamination (2012) (15)
PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1 (2019) (15)
Neural cell adhesion molecule isoform 140 declines with rise of WHO grade in human gliomas and serves as indicator for the invasion zone of multiform glioblastomas and brain metastases (2011) (15)
Biological and biochemical characterization of cell lines derived from initiation-promotion transformed C3H/10T1/2 cells. (1987) (15)
NUMB does not impair growth and differentiation status of experimental gliomas. (2011) (14)
Effects of photodynamic therapy on glioma spheroids. (1997) (14)
The relative resistance of non-cycling cells in 9L multicellular spheroids to spirohydantoin mustard. (1983) (14)
Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection (2020) (14)
Tumour fragment spheroids from human non-small-cell lung cancer maintained in organ culture (2004) (13)
Release of replication‐deficient retroviruses from a packaging cell line: Interaction with glioma tumor spheroids in vitro (1997) (13)
Sensitive and rapid detection of beta-galactosidase expression in intact cells by microinjection of fluorescent substrate. (1995) (12)
lacZ‐neoR transfected glioma cells in syngeneic rats: Growth pattern and characterization of the host immune response against cells transplanted inside and outside the cns (2000) (12)
Experimental therapies: gene therapies and oncolytic viruses. (2016) (12)
Comment to: "Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro" by Z. Ren et al. Exp. Cell Res. 317 (2011) 2950-2957: spontaneous transformation of mesenchymal stem cells in culture: facts or fiction? (2012) (12)
Antitumor efficacy improved by local delivery of species-specific endostatin. (2006) (12)
Effects of DFMO on glioma cell proliferation, migration and invasion in vitro (2004) (11)
Cryopreservation of alginate-encapsulated recombinant cells for antiangiogenic therapy. (2004) (11)
The invasive proteome of glioblastoma revealed by laser-capture microdissection (2019) (11)
The role of growth factors in the malignant and invasive progression of intrinsic brain tumours. (1997) (11)
Melanoma brain metastasis is independent of lactate dehydrogenase A expression. (2015) (10)
Lentiviral HSV‐Tk.007‐mediated suicide gene therapy is not toxic for normal brain cells (2016) (10)
Effects of hyperoxia on human endothelial cell proliferation and morphology in vitro. (1992) (10)
Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood–Brain Barrier (2019) (10)
Stereotactic biopsies as a model for studying the interaction between gliomas and normal brain tissue in vitro. (1989) (10)
A validated prognostic nomogram for patients with newly diagnosed lower-grade gliomas in a large-scale Asian cohort (2020) (10)
Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas (2021) (10)
Three-dimensional growth of glial cell lines affects growth factor and growth factor receptor mRNA levels. (1994) (9)
Reaggregation of fetal rat brain cells in a stationary culture system I: Methodology and cell identification (1986) (8)
Invasiveness by lacZ transfected non-small-cell lung cancer cells into human bronchial tissues in vitro. (1998) (8)
Tumor versus Stromal Cells in Culture—Survival of the Fittest? (2013) (8)
Growth arrest and polyploidization induced by metahalone microtubule inhibitors on rat glioma cells in culture. (1986) (8)
Novel facets of glioma invasion. (2021) (7)
Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors (2021) (7)
Retroviral transfection of the lacZ gene from Liz-9 packaging cells to glioma spheroids 1 1 This work was supported by The Norwegian Cancer Society, The Norwegian Research Council and Familien Brynildsens Legat (1999) (7)
Non-small-cell lung carcinoma cells invade human bronchial mucosa In vitro (1998) (7)
A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells (2021) (7)
The lac-z reporter gene: a tool for in vitro studies of malignant glioma cell invasion. (1996) (6)
Organ culture of a glioblastoma from a patient with an unusually long survival. (1994) (6)
Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery (2007) (6)
DNA content and chromosomes in permanent cultured cell lines derived from malignant human gliomas. (1987) (6)
Reaggregation of fetal rat brain cells in a stationary culture system II: Ultrastructural characterization (1986) (6)
Reduced expression of proteolipid protein 2 increases ER stress‐induced apoptosis and autophagy in glioblastoma (2019) (5)
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells (2017) (5)
Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression (2015) (5)
Monolayer and Three-Dimensional Culture of Rat and Human Central Nervous System: Normal and Malignant Cells and Their Interactions (1990) (5)
Cell Encapsulation Therapy for Malignant Gliomas (2005) (4)
Cathepsin L silencing increases As2O3 toxicity in malignantly transformed pilocytic astrocytoma MPA58 cells by activating caspases 3/7 (2017) (4)
Invasion and metastasis (2006) (4)
O-1-12 Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model (1997) (4)
In vivo animal models for studying brain metastasis: value and limitations (2013) (4)
Cost of Migrat ion : Invas ion of Mal ignant Gl iomas and Impl icat ions for Treatment (2003) (3)
Angiogenesis and Invasion (2010) (3)
P04.44 Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma (2018) (3)
Interaction between human medulloblastomas and foetal rat brain aggregates in vitro (2005) (3)
SPOT-006 Stem cell-associated heterogeneity in glioblastoma is a result of intrinsic tumour plasticity shaped by the microenvironment (2018) (2)
ANGI-02. INHIBITION OF APLN-APLNR SIGNALLING BLOCKS TUMOUR ANGIOGENESIS AND ATTENUATES INVASIVE GLIOBLASTOMA GROWTH (2017) (2)
Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF- k B Signaling (2019) (2)
Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis (2022) (2)
Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors (2021) (2)
Tumor-penetrating peptide for systemic targeting of Tenascin-C (2020) (2)
Correction: A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1 (2013) (2)
CELL BIOLOGY AND SIGNALING (2010) (2)
Gene Set Based Integrated Data Analysis Reveals Phenotypic Differences in a Brain Cancer Model (2013) (2)
Primary organ-culture of nonneoplastic and neoplastic thyroid-tissue as multicellular spheroids. (1995) (1)
Abstract 4413: Thrombospondin-1 is a master regulator of glioblastoma vascularization and infiltration (2016) (1)
Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes (2019) (1)
[Tumor invasion and proteases]. (1990) (1)
P06.08 Thrombospondin-1 is a master regulator of glioblastoma vascularization and infiltration (2016) (1)
Poorly oxidizable fatty acid analogues inhibit the proliferation of cancer cells in culture. (1999) (1)
IN ORGAN CULTURE (1987) (1)
Spheroid Culture in Cancer Research (1991) (2017) (1)
Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis (2021) (1)
Practical Considerations for Omics Experiments in Biomedical Sciences. (2015) (1)
Tumor Spheroids from Monolayer Cultures (2017) (1)
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment (2019) (1)
Running title : HAMLET in tumor cell apoptosis Title : HAMLET KILLS TUMOR CELLS BY APOPTOSIS-CELLULAR , MOLECULAR AND THERAPEUTIC ASPECTS (2003) (1)
AI-10DISTINCT EGFR SIGNALING IN GLIOBLASTOMA: WILD-TYPE EGFR PROMOTES INVASION WHILE EGFRvIII DRIVES PROTOTYPICAL SFK c-SRC ACTIVATION TO FOSTER ANGIOGENESIS. (2014) (1)
Specific expression of lactate dehydrogenases in glioblastoma controls intercellular lactate transfer to promote tumor growth and invasion (2021) (1)
Angiogene mekanismer ved kreft (2000) (1)
TM-14THE ANGIOGENIC SWITCH LEADS TO A METABOLIC SWITCH IN HUMAN GLIOBLASTOMA. (2014) (1)
Glioblastoma: a prognostic value of AMT-PET? (2019) (1)
Survival Xenografts by an Apoptosis-Like Mechanism and Prolongs ( HAMLET ) Kills Human Glioblastoma Cells in Brain-Lactalbumin Made Lethal to Tumor Cells (2004) (1)
Omics and Prognostic Markers (2010) (1)
Tumor Spheroids from Biopsy Specimens (2017) (1)
Abstract 1725: Activation of the p53 pathway by the MDM2 antagonist nutlin-3 downregulates the DNA repair protein hABH2 and sensitizes glioma cells to chemotherapy (2011) (1)
Metabolic effects of 3-thia fatty acid in cancer cells. (1999) (1)
DDEL-19PENETRATION OF HOMING PEPTIDE-FUNCTIONALIZED NANOPARTICLES TO GLIOMA SPHEROIDS IN VITRO (2015) (1)
BMET-34DRUG REPURPOSING DISCOVERS BETA-SITOSTEROL AS AN EFFECTIVE THERAPEUTIC AGENT AGAINST MELANOMA BRAIN METASTASES IN VIVO (2015) (1)
TMOD-08. PRIMARY AND RECURRENT GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOX) REPRESENT RELEVANT PATIENT AVATARS FOR PRECISION MEDICINE (2020) (1)
Amplifying small amounts of tumor DNA allows detection of DNA copy number abberations with array-CGH. (2008) (1)
EXTH-68. RECURRENT XENOGRAFT TUMORS UPREGULATE EGFR AFTER LENTIVIRAL VECTOR MEDIATED SUICIDE GENE THERAPY FOR GLIOBLASTOMA, BUT ARE RESISTANT TO COMBINATORIAL TREATMENT WITH ERLOTINIB (2017) (1)
BSCI-12. Inhibition of melanoma brain metastasis by targeting miR-146a (2021) (0)
Acknowledgement to Reviewers (1994) (0)
The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors (2017) (0)
O10.03PHYSIOLOGICAL AND BIOLOGICAL RESPONSES OF HUMAN GLIOBLASTOMAS TO BEVACIZUMAB TREATMENT ASSESSED BY METABOLOMIC FLUX ANALYSIS (2014) (0)
Abstract 4036: Drug repurposing to treat melanoma brain metastases (2014) (0)
P15.02 Loss of Williams Syndrome Transcription Factor (WSTF) leads to improved temozolomide sensitivity in human glioblastoma cells irrespective of MGMT expression (2021) (0)
CBIO-15. LOSS OF WILLIAMS SYNDROME TRANSCRIPTION FACTOR (WSTF) LEADS TO IMPROVED TEMOZOLOMIDE SENSITIVITY IN HUMAN GLIOBLASTOMA CELLS IRRESPECTIVE OF MGMT EXPRESSION (2021) (0)
Abstracts for the Tenth International Conference on Brain Tumour Research and Therapy (2005) (0)
Targeting dopamine receptor 2 (DRD2) signaling in combination with temozolomide chemotherapy as a novel therapeutic concept in glioblastomas. (2015) (0)
Abstracts for the Tenth International Conference on Brain Tumour Research and Therapy (2005) (0)
P17.30ONCOGENIC EGFRVIII DRIVES PROTOTYPICAL SFK C-SRC ACTIVATION TO PROMOTE GLIOBLASTOMA ANGIOGENESIS. (2014) (0)
AI-01. CASE REPORT: OPTIC NEUROPATHY IN A PATIENT WITH GLIOBLASTOMA RECEIVING BEVACIZUMAB (2010) (0)
Animal Models for Low-Grade Gliomas (2013) (0)
THER-11. PEPTIDE-MEDIATED PERMEABILIZATION OF THE BLOOD-BRAIN BARRIER IMPROVES DRUG DELIVERY TO BRAIN METASTASIS (2019) (0)
P11.52 Reduced expression of proteolipid protein 2 increases ER-stress-induced apoptosis and autophagy in glioblastoma (2019) (0)
P05.01 Patient-derived xenograft (PDX) model of glioblastoma: from basic research to preclinical studies (2016) (0)
15 Cancer stem cells: current controversies (2010) (0)
P01.19A GENOME-WIDE RNAI SYNTHETIC LETHAL SCREEN FOR SENSITIZERS OF GLIOBLASTOMA MULTIFORME TO TEMOZOLOMIDE. (2014) (0)
Abstract LB-295: Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma (2019) (0)
TMOD-29. MOLECULAR CHARACTERIZATION OF GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS: FROM BASIC RESEARCH TO PRECLINICAL STUDIES (2018) (0)
Abstract LB-314: The good drug, the bad barrier and the handy peptide: Improved treatment of experimental melanoma brain metastases using a synthetic peptide (2018) (0)
Iterative Methods for Fast Reconstruction of Undersampled Dynamic Contrast-Enhanced MRI Data (2018) (0)
FSMP-07. CYSTATHIONINE-Γ-LYASE DRIVES ANTIOXIDANT DEFENSE IN CYSTEINE-RESTRICTED IDH1 MUTANT ASTROCYTOMAS (2021) (0)
P12.09.B Extracellular vesicle derived-miR-146a increases melanoma brain metastasis progression via Notch signalling pathway dysregulation (2022) (0)
Cell Migration of Neural and Neoplastic Cells Transplanted into the Adult Rat Brain (1994) (0)
Host cell recruitment by gliomas (2008) (0)
P-3-265 Human medulloblastomas and foetal rat brain aggregates. Interaction and invasiveness (1997) (0)
Kreft og vert (2006) (0)
O-9-127 Microtubules as a target for chemotherapeutic agents: Paclitaxel (Taxol®) inhibits invasion of glioma cells (1997) (0)
Deciphering Human Glioblastoma Invasion Using a Developmental Mature Rat Brain Organoid Model (2022) (0)
LAB-METABOLIC PATHWAYS (2012) (0)
PO-197 Patient-derived xenograft (PDX) models of glioblastoma: from basic research to preclinical studies (2018) (0)
Abstract 1331: Targeting CD47 triggers macrophage-dependent brain tumor destruction in a clinical relevant model (2015) (0)
EXTH-32. NOVEL THIORIDAZINE DERIVATES: ANTIPROLIFERATIVE AND APOPTOSIS-INDUCING ACTIVITY ON GLIOBLASTOMA CELLS IN VITRO (2021) (0)
BM-34NEW USES OF OLD DRUGS FOR THE CLINICAL TREATMENT OF BRAIN METASTASES (2014) (0)
Abstract LB-518: Amplification and activation of EGFR wild-type mediates invasion of human glioblastoma in vivo (2012) (0)
272 INVITED Optimising Treatment in Gliomas – Translational (2011) (0)
DDIS-21. APPLICATION OF A FUNCTIONAL GENETICS APPROACH TO IDENTIFY PHARMACOLOGICAL INHIBITORS OF HIF-1α (2017) (0)
161 INVITED Stem Cells (2011) (0)
Interaction Between Brain Tissue and Malignant Glioma Cells in Organ Culture (1987) (0)
558 Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells (2010) (0)
MAPPING THE GLIOBLASTOMA METABOLOME AFTER BEVACIZUMAB THERAPY BY 13C6-GLUCOSE METABOLOMIC FLUX ANALYSIS. (2014) (0)
OS6.2 Loss of CYP46A1 directs altered cholesterol homeostasis and opens therapeutic opportunities for glioblastoma (2019) (0)
A new chance for EGFR inhibition in glioblastoma? (2019) (0)
CD47 antibody inhibits tumor recurrence in a clinical relevant glioblastoma animal model (2015) (0)
Infection of rat brain cell aggregates with neurovirulent and nonneurovirulent strains of herpes simplex virus type 1. (1999) (0)
LAB-STEM CELLS (2012) (0)
249 Side Population in Human Glioblastoma Does Not Characterize Cancer Stem Cell Populations and is Exclusively Stroma-derived (2012) (0)
Tumor Models (In Vivo/In Vitro) (2010) (0)
Primary and recurrent glioma patient-derived orthotopic xenografts (PDOX) represent relevant patient avatars for precision medicine (2020) (0)
Abstract 1343: P32-targeting TT1 peptide delivers nanoparticles to intracranial glioblastomas (2016) (0)
Centrifugal elutriation of 9L rat brain tumor cells (1981) (0)
Deciphering the complex role of thrombospondin-1 in glioblastoma development (2019) (0)
TMOD-34. IMPROVED TREATMENT OF MELANOMA BRAIN METASTASIS USING A SYNTHETIC PEPTIDE (2018) (0)
P16.24MULTIMODAL IMAGING ELUCIDATES PHYSIOLOGICAL AND METABOLIC CHANGES INDUCED BY ANTI-ANGIOGENIC THERAPY IN GLIOBLASTOMA (2014) (0)
224 A new lytic peptide for the treatment of cancer (2010) (0)
RETROVIRUS PRODUCTION FROM PACKAGING CELLS AND GENE TRANSFER. INTO SPHEROIDS OF GLIOMA ORIGIN (1997) (0)
Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis (2012) (0)
Acknowledgment of Reviewers (1996) (0)
P13.16 Metastatic potential of systemic glioblastoma stem cell lines in vivo (2021) (0)
[Angiogenic mechanisms in cancer]. (2000) (0)
Synthesis of novel Thioridazine derivates: in-vitro cytotoxicity and anticancer effect on glioblastoma (2021) (0)
ANGI-03. PHARMACOLOGICAL TARGETING OF APELIN/APLNR SIGNALING BLUNTS THERAPY RESISTANCE TO VEGFA/VEGFR2 ANTI-ANGIOGENIC TREATMENT IN GLIOBLASTOMA (2019) (0)
P13.04 K16ApoE increases drug-delivery across the blood brain barrier in an animal model of brain metastases (2017) (0)
Cost o f M igration: I nvasion o f M alignant G liomas a nd Implications f or T reatment (2003) (0)
IN SITU METABOLIC PROFILING SHEDS LIGHT ON OXIDATIVE STRESS PATHWAYS IN IDH1 MUTANT OLIGODENDROGLIOMA (2014) (0)
1211 POSTER Treatment of Solid Cancers Using a New Cationic Cytolytic Peptide (2011) (0)
Abstract 2865: The peptide transporter K16ApoE increases drug delivery across the blood brain barrier in an experimental animal model of melanoma brain metastases (2017) (0)
Abstract B84: Activated c-Src enhances hypoxia in human glioblastoma multiforme and promotes tumor angiogenesis (2013) (0)
Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination (2017) (0)
Correction: Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression (2015) (0)
In situ metabolic profiling of IDH-mutant glioma (2019) (0)
CSIG-37. TGF-β PROMOTES MEMBRANE TUBE FORMATION IN GLIOBLASTOMA THAT CONTRIBUTES TO INVASION AND THERAPY RESISTANCE (2017) (0)
Brain Tumour Cell Invasion: Possible Role of Lysosomal Enzymes (1987) (0)
NON-SMALL-CELL LUNG CARCINOMA CELLS INVADE HUMAN BRONCHIAL (1998) (0)
OS06.6A Inhibition of GBM invasion by the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor antagonist Perampanel (2021) (0)
OS12.2 Targeting epigenetic pathways in the treatment of recurrent high-grade glioma (2019) (0)
GENE-02. ESTABLISHING PERSONALIZED TREATMENT OPTIONS FOR RECURRENT HIGH-GRADE GLIOMAS (2019) (0)
Alpha-B-crystallin: a novel protein associated with invasive glioma phenotype (2006) (0)
Development of a new brain metastates model in the nude rat (2008) (0)
19 – Transplants for Glioblastoma (2007) (0)
475. Effects of HSV-Tk Mediated Suicide Gene Therapy on Normal Brain Cells (2016) (0)
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis (2019) (0)
AI-010. ACTIVATION OF THE PROTOTYPICAL SFK C-Src PROMOTES ANGIOGENESIS OF HUMAN GLIOBLASTOMA (2013) (0)
CD133-negative glioma cells form tumours, while the onset of CD133 expression coincides with angiogenesis and shortened survival (2007) (0)
Abstract 2650: Age-dependent association between protein expression of the embryonic stem cell marker Cripto-1 and survival of glioblastoma patients. (2013) (0)
AI-010. ACTIVATION OF THE PROTOTYPICAL SFK C-Src PROMOTES ANGIOGENESIS OF HUMAN GLIOBLASTOMA (2013) (0)
Abstract 5229: Single, pre-labeled metastatic melanoma cells can be detected in the mouse brain using MRI (2011) (0)
OS6.3 The complex role of lactate dehydrogenases in glioblastoma development (2019) (0)
CSIG-28. LONG NONCODING RNA MIR22 HOST GENE-DERIVED miR-22-3p AND miR-22-5p PROMOTE PROLIFERATION, INVASION AND SELF-RENEWAL IN HUMAN GLIOMAS VIA Wnt/-CATENIN SIGNALING (2018) (0)
TAMI-24. INHIBITION OF GBM INVASION BY THE Α-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (AMPA) GLUTAMATE RECEPTOR ANTAGONIST PERAMPANEL (2021) (0)
200: Potential therapeutic targets for the hypoxic niche in glioblastoma (2014) (0)
P13.08 Novel Thioridazine derivates: Antiproliferative and apoptosis-inducing activity on glioblastoma cells in vitro (2021) (0)
DS-04DOPAMINE ADDICTION IN GLIOBLASTOMA MULTIFORME DURING CHEMOTHERAPY IS MEDIATED BY A DRD2/β-ARRESTIN/AKT SIGNALING COMPLEX (2014) (0)
P11.57 A 3D brain organoid coculture system delineates the invasive cell components in glioblastoma (2019) (0)
ATPS-59IMPROVING EFFICACY OF BEVACIZUMAB TREATMENT IN GLIOBLASTOMA BY TARGETING HIF1 ALPHA (2015) (0)
METB-09IDENTIFYING NOVEL VULNERABILITIES IN OXIDATIVE STRESS PATHWAYS IN IDH1 MUTANT GLIOMA (2015) (0)
Abstract 3641: The DNA repair protein hABH2 mediates temozolomide resistance in human glioblastoma cells (2010) (0)
The Implication of Anti-angiogenic Treatment of Malignancies on Human Metabolism (2019) (0)
STEM-09. INTRINSIC TUMOR PLASTICITY IN GLIOBLASTOMA ALLOWS FOR RECREATION OF STEM LIKE-STATES AND EFFICIENT TUMOR CELL ADAPTATION TO NEW MICROENVIRONMENTS (2019) (0)
P04.87 Delineating the invasive component of human brain tumors using brain organoids (2018) (0)
Abstract 5279: Over-expression of EGFRviii induces an angiogenic switch in infiltrative human glioblastomas (2012) (0)
Abstract 2699: Organ-specific signatures of melanoma metastasis. (2013) (0)
PL3.4 Intrinsic tumor plasticity in Glioblastoma allows for recreation of stem like-states and efficient tumor cell adaptation to new microenvironments (2019) (0)
EXTH-31. CONTINUOUS ADMINISTRATION OF VALGANCICLOVIR IMPROVES LENTIVIRAL VECTOR MEDIATED SUICIDE GENE THERAPY FOR GLIOBLASTOMA (2016) (0)
P04.64 Molecular characterization of glioma patient derived orthotopic xenografts to improve outcome of preclinical studies (2018) (0)
Endostatin Gene Transduction of Glioma Cells Modifies Brain Tumor Development: Assessment by MRI (2001) (0)
P16.08 Inhibition of melanoma brain metastasis by targeting miR-146a (2020) (0)
[abstract] FLOW CYTOMETRIC MEASUREMENTS OF PLATELET ACTIVATION CAUSED BY MICROBUBBLES IN VITRO. (1989) (0)
ANGI-06. THE MATRIX PROTEIN THROMBOSPONDIN-1 IS A DOWNSTREAM TARGET OF TGF-β INDUCED MICROTUBE FORMATION IN GLIOBLASTOMA (2018) (0)
- 1-Improved drug delivery to brain metastases by peptide-mediated 1 permeabilization of the blood-brain barrier 2 3 (2019) (0)
Multi-modal molecular imaging of anti-angiogenic treatment strategies of experimental gliomas (2011) (0)
294 Successful engraftment of glioblastoma biopsy spheroids in immunocompetent rats (2010) (0)
[Tumor heterogeneity. Basal aspects of significance for therapeutic strategy]. (1988) (0)
OTME-14. TGF-beta signaling in microtube formation of glioblastoma (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Rolf Bjerkvig?

Rolf Bjerkvig is affiliated with the following schools:

Rolf Bjerkvig's Academic­Influence.com Rankings

Why Is Rolf Bjerkvig Influential?

Rolf Bjerkvig's Published Works

Published Works

What Schools Are Affiliated With Rolf Bjerkvig?

Rolf Bjerkvig's AcademicInfluence.com Rankings